Physician profile
Meaghan Brown
NPI 1699250787
$4,010.85
in general payments reported to CMS, 2019-2025
44 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.07 · 2022: $13.70 · 2023: $1,396 · 2024: $1,088 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452 · Education: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.13 |
| Education | $493.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $405.12 | 2023-2025 | Tagrisso, Calquence, Lynparza |
| Merck Sharp & Dohme LLC | $401.71 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $237.07 | 2024-2025 | |
| Eisai INC. | $188.00 | 2023-2025 | |
| Abbvie INC. | $186.90 | 2023-2025 | |
| Glaxosmithkline, LLC. | $183.36 | 2023-2025 | Ojjaara, Blenrep |
| Takeda Pharmaceuticals U.S.A., INC. | $176.20 | 2023-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Incyte Corporation | $159.94 | 2023-2025 | Monjuvi, Jakafi |
| Pharmaessentia USA Corporation | $157.04 | 2024-2025 | Besremi |
| Daiichi Sankyo INC. | $141.73 | 2024-2025 | Enhertu, Datroway |
| Janssen Biotech, INC. | $134.22 | 2023-2025 | Rybrevant, Erleada, Talvey |
| Lilly USA, LLC | $126.46 | 2023-2025 | Jaypirca, Verzenio, Retevmo |
| Exelixis INC. | $117.87 | 2023-2024 | Cabometyx |
| Seagen INC. | $117.59 | 2023-2024 | Adcetris |
| Astellas Pharma US INC | $95.08 | 2021-2024 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.